Previous Close | 3.2500 |
Open | 3.4100 |
Bid | 1.4200 x 1100 |
Ask | 4.3300 x 1000 |
Day's Range | 2.6400 - 3.4100 |
52 Week Range | 2.1500 - 8.8000 |
Volume | |
Avg. Volume | 22,349 |
Market Cap | 29.102M |
Beta (5Y Monthly) | -0.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.4480 |
Earnings Date | May 08, 2023 - May 12, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14.00 |
LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good morning, and thank you for your participation. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. As a reminder, this conference call will be recorded. I would now like to turn the conference over […]
ORLANDO, Fla., March 16, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter and full year ended December 31, 2022 and provided an update on key operational initiatives.
ORLANDO, Fla., March 09, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 2022 financial results will be released before market open on Thursday, March 16, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, March 16, 2023 to discuss the financial results